buthionine sulfoximine has been researched along with sphingosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Allen, K; Griffiths, HR; Phillips, DC | 1 |
| Frgala, T; Kalous, O; Proffitt, RT; Reynolds, CP | 1 |
3 other study(ies) available for buthionine sulfoximine and sphingosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthetic ceramides induce growth arrest or apoptosis by altering cellular redox status.
Topics: Apoptosis; Buthionine Sulfoximine; Cell Division; Cells, Cultured; Ceramides; Dose-Response Relationship, Drug; Glutathione; Humans; Jurkat Cells; Leukemia, T-Cell; Mitochondria; Monocytes; Oxidation-Reduction; Peroxides; Reactive Oxygen Species; Rotenone; Sphingosine | 2002 |
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Eosine Yellowish-(YS); Fenretinide; Fluorescent Dyes; Humans; Leukemia; Melphalan; Microscopy, Fluorescence; Neuroblastoma; Protein Kinase C; Sphingosine; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2007 |